Home › Finnish Dx Firm Blueprint Genetics Raises €14M

Finnish Dx Firm Blueprint Genetics Raises €14M

Jul 13, 2017

NEW YORK (GenomeWeb) – Blueprint Genetics this week announced it raised €14 million ($16 million) in a new financing round, bringing the total investment in its history to €23 million.

The financing round was led by new investors Creathor Venture and MedTech Innovation Partners. Existing investors Inventure and Pontos Group also participated.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

What's Popular?

In Business News

  1. Great Basin in Default of Senior Notes for $18.3M

  2. Color Raises $52M of Planned $80M Financing

  3. Cancer Genetics Q2 Revenues Down 6 Percent; Acquires VivoPharm for $12M

  4. Thermo Fisher Scientific Enters Into $1.5B Loan Facility

  5. Oncocyte Q2 Net Loss Widens, First Test Still Slated for Q4 Launch

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.